| Enterprise Revenue | $8.8B | Q1 actual (prepared) |
| Domestic Revenue | $8.1B | Q1 actual (prepared) |
| International Revenue | $640M | Q1 actual (prepared) |
| Domestic Comparable Sales | -0.7% | Q1 actual (prepared) |
| Enterprise Comparable Sales | -0.7% | Q1 actual (prepared) |
| Adjusted Operating Income Rate | 3.8% | Q1 actual (prepared) |
| Adjusted Diluted EPS | $1.15 | Q1 actual (prepared) |
| Domestic Gross Profit Rate | 23.5% | Q1 actual, +10 bps YoY (CFO) |
| International Gross Profit Rate | 22.0% | Q1 actual, -80 bps YoY (CFO) |
| Online Sales % of Domestic | ~32% | Q1 actual (CEO) |
| Shareholder Returns (Q1) | $302M | Dividends $202M + buybacks $100M (CFO) |
| Restructuring Charges (Q1) | $109M | Primarily Best Buy Health (CFO) |
| FY26 Revenue Guidance | $41.1B – $41.9B | Full year (CFO) |
| FY26 Comparable Sales Guidance | -1% to +1% | Full year (CEO) |
| FY26 Adjusted Operating Income Rate | ~4.2% | Full year (CEO) |
| FY26 Adjusted Diluted EPS | $6.15 – $6.30 | Full year (CFO) |
| FY26 CapEx | ~$700M | Full year (CFO) |
| FY26 Share Repurchases | ~$300M | Full year (CFO) |
| Q2 Comparable Sales | Slightly down YoY | Q2 guidance (CFO) |
| Q2 Adjusted Operating Income Rate | ~3.6% | Q2 guidance (CFO) |